Surgical Division is global leader in surgical laser technology and medical laser equipment, and considered a pioneer in the field of laser for surgery


Lumenis Smart CO2 Solutions for Transoral Laser Microsurgery (TLM)

CO2 lasers are increasingly becoming a first line treatment of early stage airway cancers, especially in the larynx. Studies have shown considerable cost savings and equivalent or better treatment outcomes for transoral laser resection of laryngeal tumors in comparison to radiation.1
The use of chemotherapy, radiation therapy, or cold knife surgery in the treatment of transoral airway cancer is associated with complications that can dramatically alter facial appearance and impact the ability to swallow, talk, eat, smell, taste, hear, and breathe normally.
Alternatively, Transoral Laser Microsurgery (TLM), done with CO2 laser, offers low morbidity and excellent cure rates compared to chemoradiation.2
CO2 laser surgery does not eliminate the option for reoperation or radiation, should salvage therapy become necessary.

Immediate treatment post-surgical biopsy eliminates return visits to the Operating Room and may serve as salvage therapy for select patients with previously treated laryngeal or pharyngeal squamous cell cancer or other pathologies.
Unlike open surgery, CO2 lasers can remove cancer with fewer disturbances to structures, nerves, and tissue. Lasers can be used for a wide range of cancer procedures, recurrent papillomatosis, and clinical conditions that may cause swallowing disorders.3
TLM patients are able to swallow sooner post microsurgery, and hospital stays are typically five to seven days less than for open surgery.4
Lumenis Surgical – CO2 Laser for ENT 


Get more info
Benefits of the Smart CO2 Solutions for Transoral Laser Microsurgery
TLM Advantages:

  • Precise incision, excision, and vaporization, with microvascular hemostasis
  • Predictable, reproducible laser-tissue interaction
  • Minimal thermal damage for excellent tissue margins
  • Tumor-host interface mapping for smart margin management and minimal healthy tissue loss
  • Minimal disturbance to structures, nerves, and tissue
  • Multi-option salvage treatments in the event of recurrence
  • Suture-free procedure enables swallowing sooner post-surgery
  • Shorter hospital stays help reduce procedure costs

Treatment & Excisions:

  • Benign and malignant lesions of the oral cavity, pharynx, or larynx
  • Leukoplakia
  • Vocal cord lesions, benign and recurrent
  • Laryngeal papillomas

Lumenis advanced laser systems enable highly controlled, smart tissue management for treating delicate tissue surfaces.

The Flexible CO2 Fibers for:

  • Dependable handheld CO2 laser performance
  • Easier access to hard to reach anatomy
  • Efficient power transmission for rapid bulk tissue ablation
  • Robotic surgery applications

The Digital AcuBlade Scanning Micromanipulator:

  • Benign and malignant lesions of the oral cavity, pharynx, or larynx
  • Leukoplakia
  • Vocal cord lesions, benign and recurrent
  • Laryngeal papillomas

1. Schrijvers ML, van Riel EL, Langendijk JA, Dikkers FG, Schuuring E, van der Wal JE, van der Laan BF. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1A glottis laryngeal carcinoma, Head Neck, 2009 Jun; 31(6):759–64.
2. Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H, Haughey BH, Nussenbaum B, Steiner W, Transoral Laser Microsurgery for Advanced Laryngeal Cancer, Arch Otolaryngol Head Neck Surg, 2007 Dec; 133(12):1198-204.
3. Rich JT, Liu J, Haughey BH, Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer Laryngoscope, 2011, Nov; 121(11):2381-90.
4. Lindsey H, Transoral Laser Microsurgery a Viable Option for Head and Neck Patients, ENT Today, 2008.
General comments: 
More Information